Log In
person
Alkermes Plc
ALKS
summarize
2 total product lines
calendar_month
Revenue as of 12/31/2020
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Pharma |
Branded Pharmaceuticals
These companies research, develop, and manufacture patented drugs.
|
551.76M | 53.12% |
| Pharma |
Pharmaceutical Patent Licensing
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
487M | 46.88% |
| keyboard_arrow_down |
Pharma
Branded Pharmaceuticals
|
551.76M | 53.12% |
| keyboard_arrow_right |
These companies research, develop, and manufacture patented drugs.
|
||
| keyboard_arrow_down |
Pharma
Pharmaceutical Patent Licensing
|
487M | 46.88% |
| keyboard_arrow_right |
These companies collect royalties from pharma and biotech companies who make biotech products they developed or products that incorporate their technologies.
|
||